Sekido Y - Search Results

1

Akt kinase-interacting protein1, a novel therapeutic target for lung cancer with EGFR-activating and gatekeeper mutations.

Yamada T, Takeuchi S, Fujita N, Nakamura A, Wang W, Li Q, Oda M, Mitsudomi T, Yatabe Y, Sekido Y, Yoshida J, Higashiyama M, Noguchi M, Uehara H, Nishioka Y, Sone S, Yano S. Yamada T, et al. Among authors: sekido y. Oncogene. 2013 Sep 12;32(37):4427-35. doi: 10.1038/onc.2012.446. Epub 2012 Oct 8. Oncogene. 2013. PMID: 23045273

2

The p53 gene is very frequently mutated in small-cell lung cancer with a distinct nucleotide substitution pattern.

Takahashi T, Takahashi T, Suzuki H, Hida T, Sekido Y, Ariyoshi Y, Ueda R. Takahashi T, et al. Among authors: sekido y. Oncogene. 1991 Oct;6(10):1775-8. Oncogene. 1991. PMID: 1656362

3

Coexpression of the stem cell factor and the c-kit genes in small-cell lung cancer.

Hibi K, Takahashi T, Sekido Y, Ueda R, Hida T, Ariyoshi Y, Takagi H, Takahashi T. Hibi K, et al. Among authors: sekido y. Oncogene. 1991 Dec;6(12):2291-6. Oncogene. 1991. PMID: 1722571

4

Molecular analysis of the von Hippel-Lindau disease tumor suppressor gene in human lung cancer cell lines.

Sekido Y, Bader S, Latif F, Gnarra JR, Gazdar AF, Linehan WM, Zbar B, Lerman MI, Minna JD. Sekido Y, et al. Oncogene. 1994 Jun;9(6):1599-604. Oncogene. 1994. PMID: 8183553

5

TSG101 is not mutated in lung cancer but a shortened transcript is frequently expressed in small cell lung cancer.

Oh Y, Proctor ML, Fan YH, Su LK, Hong WK, Fong KM, Sekido YS, Gazdar AF, Minna JD, Mao L. Oh Y, et al. Among authors: sekido ys. Oncogene. 1998 Sep 3;17(9):1141-8. doi: 10.1038/sj.onc.1202029. Oncogene. 1998. PMID: 9764824

6

Mutation analysis of the PTEN/MMAC1 gene in lung cancer.

Forgacs E, Biesterveld EJ, Sekido Y, Fong K, Muneer S, Wistuba II, Milchgrub S, Brezinschek R, Virmani A, Gazdar AF, Minna JD. Forgacs E, et al. Among authors: sekido y. Oncogene. 1998 Sep 24;17(12):1557-65. doi: 10.1038/sj.onc.1202070. Oncogene. 1998. PMID: 9794233

7

Genetic alteration of the beta-catenin gene (CTNNB1) in human lung cancer and malignant mesothelioma and identification of a new 3p21.3 homozygous deletion.

Shigemitsu K, Sekido Y, Usami N, Mori S, Sato M, Horio Y, Hasegawa Y, Bader SA, Gazdar AF, Minna JD, Hida T, Yoshioka H, Imaizumi M, Ueda Y, Takahashi M, Shimokata K. Shigemitsu K, et al. Among authors: sekido y. Oncogene. 2001 Jul 12;20(31):4249-57. doi: 10.1038/sj.onc.1204557. Oncogene. 2001. PMID: 11464291

8

Induction of antitumor immunity by transduction of CD40 ligand gene and interferon-gamma gene into lung cancer.

Noguchi M, Imaizumi K, Kawabe T, Wakayama H, Horio Y, Sekido Y, Hara T, Hashimoto N, Takahashi M, Shimokata K, Hasegawa Y. Noguchi M, et al. Among authors: sekido y. Cancer Gene Ther. 2001 Jun;8(6):421-9. doi: 10.1038/sj.cgt.7700320. Cancer Gene Ther. 2001. PMID: 11498762

9

Overexpression of candidate tumor suppressor gene FUS1 isolated from the 3p21.3 homozygous deletion region leads to G1 arrest and growth inhibition of lung cancer cells.

Kondo M, Ji L, Kamibayashi C, Tomizawa Y, Randle D, Sekido Y, Yokota J, Kashuba V, Zabarovsky E, Kuzmin I, Lerman M, Roth J, Minna JD. Kondo M, et al. Among authors: sekido y. Oncogene. 2001 Sep 27;20(43):6258-62. doi: 10.1038/sj.onc.1204832. Oncogene. 2001. PMID: 11593436

10

The expression of DNA methyltransferases and methyl-CpG-binding proteins is not associated with the methylation status of p14(ARF), p16(INK4a) and RASSF1A in human lung cancer cell lines.

Sato M, Horio Y, Sekido Y, Minna JD, Shimokata K, Hasegawa Y. Sato M, et al. Among authors: sekido y. Oncogene. 2002 Jul 18;21(31):4822-9. doi: 10.1038/sj.onc.1205581. Oncogene. 2002. PMID: 12101420

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

290 results

Search Page

Filters